Prezzo di chiusura
Altri mercati azionari
|
||
- PTS | - |
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01/12/08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18/04/22 |
Chief Tech/Sci/R&D Officer | - | 01/07/17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 24/05/18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 07/11/22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 17/01/19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 01/01/17 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 01/09/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08/06/17 |
Harold Selick
CHM | Chairman | 69 | 01/02/09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26/10/23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01/12/08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 12/08/20 |
William Waddill
BRD | Director/Board Member | 67 | 01/07/16 |
Bryan Giraudo
BRD | Director/Board Member | 49 | 16/05/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 58 652 133 | 56 902 179 ( 97,02 %) | 0 | 97,02 % |
Coordinate società
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,83% | 46,56 Mrd | |
+45,38% | 41,67 Mrd | |
+0,69% | 41,16 Mrd | |
+30,52% | 32,4 Mrd | |
+22,30% | 28,18 Mrd | |
-6,35% | 28,1 Mrd | |
+49,25% | 14,52 Mrd | |
+49,18% | 13,74 Mrd | |
+3,45% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione PTGX
- Azione
- Società Protagonist Therapeutics Inc